Scopolamine API Market To Witness Substantial Growth, 2026-2033 | Aspen Holdings, LGM Pharma, Midas Pharma GmbH
The global scopolamine API market is estimated to be valued at US$ 292.96 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast. BURLINGAME, CA, UNITED STATES, January 22, 2026 /EINPresswire.com/ -- The latest report by …